Medical Care
Global Exosome Therapeutics Market Research Report 2025
- May 05, 25
- ID: 226389
- Pages: 73
- Figures: 73
- Views: 39
The global market for Exosome Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Exosome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Exosome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Exosome Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Exosome Therapeutics include Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, EV Therapeutics, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, SHIFTBIO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapeutics.
The Exosome Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exosome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Exosome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Exosome Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Exosome Therapeutics in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Exosome Therapeutics include Cellular Biomedicine Group, Codiak BioSciences, Coya Therapeutics, Curexsys, EV Therapeutics, Evox Therapeutics, ExoCoBio, ILIAS Biologics, Rion, SHIFTBIO, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exosome Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exosome Therapeutics.
The Exosome Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exosome Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exosome Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellular Biomedicine Group
Codiak BioSciences
Coya Therapeutics
Curexsys
EV Therapeutics
Evox Therapeutics
ExoCoBio
ILIAS Biologics
Rion
SHIFTBIO
Segment by Type
Monotherapy
Combination Therapy
Segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosome Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Exosome Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapeutics Market Perspective (2020-2031)
2.2 Global Exosome Therapeutics Growth Trends by Region
2.2.1 Global Exosome Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Exosome Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Exosome Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Exosome Therapeutics Market Dynamics
2.3.1 Exosome Therapeutics Industry Trends
2.3.2 Exosome Therapeutics Market Drivers
2.3.3 Exosome Therapeutics Market Challenges
2.3.4 Exosome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapeutics Players by Revenue
3.1.1 Global Top Exosome Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Exosome Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Exosome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Therapeutics Revenue
3.4 Global Exosome Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics Revenue in 2024
3.5 Global Key Players of Exosome Therapeutics Head office and Area Served
3.6 Global Key Players of Exosome Therapeutics, Product and Application
3.7 Global Key Players of Exosome Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapeutics Breakdown Data by Type
4.1 Global Exosome Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Exosome Therapeutics Forecasted Market Size by Type (2026-2031)
5 Exosome Therapeutics Breakdown Data by Application
5.1 Global Exosome Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Exosome Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Exosome Therapeutics Market Size (2020-2031)
6.2 North America Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Exosome Therapeutics Market Size by Country (2020-2025)
6.4 North America Exosome Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapeutics Market Size (2020-2031)
7.2 Europe Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Exosome Therapeutics Market Size by Country (2020-2025)
7.4 Europe Exosome Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Exosome Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Exosome Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Exosome Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapeutics Market Size (2020-2031)
9.2 Latin America Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Exosome Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Exosome Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Exosome Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Exosome Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellular Biomedicine Group
11.1.1 Cellular Biomedicine Group Company Details
11.1.2 Cellular Biomedicine Group Business Overview
11.1.3 Cellular Biomedicine Group Exosome Therapeutics Introduction
11.1.4 Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2020-2025)
11.1.5 Cellular Biomedicine Group Recent Development
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapeutics Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapeutics Business (2020-2025)
11.2.5 Codiak BioSciences Recent Development
11.3 Coya Therapeutics
11.3.1 Coya Therapeutics Company Details
11.3.2 Coya Therapeutics Business Overview
11.3.3 Coya Therapeutics Exosome Therapeutics Introduction
11.3.4 Coya Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.3.5 Coya Therapeutics Recent Development
11.4 Curexsys
11.4.1 Curexsys Company Details
11.4.2 Curexsys Business Overview
11.4.3 Curexsys Exosome Therapeutics Introduction
11.4.4 Curexsys Revenue in Exosome Therapeutics Business (2020-2025)
11.4.5 Curexsys Recent Development
11.5 EV Therapeutics
11.5.1 EV Therapeutics Company Details
11.5.2 EV Therapeutics Business Overview
11.5.3 EV Therapeutics Exosome Therapeutics Introduction
11.5.4 EV Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.5.5 EV Therapeutics Recent Development
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapeutics Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.6.5 Evox Therapeutics Recent Development
11.7 ExoCoBio
11.7.1 ExoCoBio Company Details
11.7.2 ExoCoBio Business Overview
11.7.3 ExoCoBio Exosome Therapeutics Introduction
11.7.4 ExoCoBio Revenue in Exosome Therapeutics Business (2020-2025)
11.7.5 ExoCoBio Recent Development
11.8 ILIAS Biologics
11.8.1 ILIAS Biologics Company Details
11.8.2 ILIAS Biologics Business Overview
11.8.3 ILIAS Biologics Exosome Therapeutics Introduction
11.8.4 ILIAS Biologics Revenue in Exosome Therapeutics Business (2020-2025)
11.8.5 ILIAS Biologics Recent Development
11.9 Rion
11.9.1 Rion Company Details
11.9.2 Rion Business Overview
11.9.3 Rion Exosome Therapeutics Introduction
11.9.4 Rion Revenue in Exosome Therapeutics Business (2020-2025)
11.9.5 Rion Recent Development
11.10 SHIFTBIO
11.10.1 SHIFTBIO Company Details
11.10.2 SHIFTBIO Business Overview
11.10.3 SHIFTBIO Exosome Therapeutics Introduction
11.10.4 SHIFTBIO Revenue in Exosome Therapeutics Business (2020-2025)
11.10.5 SHIFTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Exosome Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics & Ambulatory Centers
1.3.4 Cancer Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapeutics Market Perspective (2020-2031)
2.2 Global Exosome Therapeutics Growth Trends by Region
2.2.1 Global Exosome Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Exosome Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Exosome Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Exosome Therapeutics Market Dynamics
2.3.1 Exosome Therapeutics Industry Trends
2.3.2 Exosome Therapeutics Market Drivers
2.3.3 Exosome Therapeutics Market Challenges
2.3.4 Exosome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome Therapeutics Players by Revenue
3.1.1 Global Top Exosome Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Exosome Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Exosome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exosome Therapeutics Revenue
3.4 Global Exosome Therapeutics Market Concentration Ratio
3.4.1 Global Exosome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapeutics Revenue in 2024
3.5 Global Key Players of Exosome Therapeutics Head office and Area Served
3.6 Global Key Players of Exosome Therapeutics, Product and Application
3.7 Global Key Players of Exosome Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapeutics Breakdown Data by Type
4.1 Global Exosome Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Exosome Therapeutics Forecasted Market Size by Type (2026-2031)
5 Exosome Therapeutics Breakdown Data by Application
5.1 Global Exosome Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Exosome Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Exosome Therapeutics Market Size (2020-2031)
6.2 North America Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Exosome Therapeutics Market Size by Country (2020-2025)
6.4 North America Exosome Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome Therapeutics Market Size (2020-2031)
7.2 Europe Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Exosome Therapeutics Market Size by Country (2020-2025)
7.4 Europe Exosome Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exosome Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Exosome Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Exosome Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Exosome Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exosome Therapeutics Market Size (2020-2031)
9.2 Latin America Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Exosome Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Exosome Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Exosome Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Exosome Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Exosome Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellular Biomedicine Group
11.1.1 Cellular Biomedicine Group Company Details
11.1.2 Cellular Biomedicine Group Business Overview
11.1.3 Cellular Biomedicine Group Exosome Therapeutics Introduction
11.1.4 Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2020-2025)
11.1.5 Cellular Biomedicine Group Recent Development
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapeutics Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapeutics Business (2020-2025)
11.2.5 Codiak BioSciences Recent Development
11.3 Coya Therapeutics
11.3.1 Coya Therapeutics Company Details
11.3.2 Coya Therapeutics Business Overview
11.3.3 Coya Therapeutics Exosome Therapeutics Introduction
11.3.4 Coya Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.3.5 Coya Therapeutics Recent Development
11.4 Curexsys
11.4.1 Curexsys Company Details
11.4.2 Curexsys Business Overview
11.4.3 Curexsys Exosome Therapeutics Introduction
11.4.4 Curexsys Revenue in Exosome Therapeutics Business (2020-2025)
11.4.5 Curexsys Recent Development
11.5 EV Therapeutics
11.5.1 EV Therapeutics Company Details
11.5.2 EV Therapeutics Business Overview
11.5.3 EV Therapeutics Exosome Therapeutics Introduction
11.5.4 EV Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.5.5 EV Therapeutics Recent Development
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapeutics Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapeutics Business (2020-2025)
11.6.5 Evox Therapeutics Recent Development
11.7 ExoCoBio
11.7.1 ExoCoBio Company Details
11.7.2 ExoCoBio Business Overview
11.7.3 ExoCoBio Exosome Therapeutics Introduction
11.7.4 ExoCoBio Revenue in Exosome Therapeutics Business (2020-2025)
11.7.5 ExoCoBio Recent Development
11.8 ILIAS Biologics
11.8.1 ILIAS Biologics Company Details
11.8.2 ILIAS Biologics Business Overview
11.8.3 ILIAS Biologics Exosome Therapeutics Introduction
11.8.4 ILIAS Biologics Revenue in Exosome Therapeutics Business (2020-2025)
11.8.5 ILIAS Biologics Recent Development
11.9 Rion
11.9.1 Rion Company Details
11.9.2 Rion Business Overview
11.9.3 Rion Exosome Therapeutics Introduction
11.9.4 Rion Revenue in Exosome Therapeutics Business (2020-2025)
11.9.5 Rion Recent Development
11.10 SHIFTBIO
11.10.1 SHIFTBIO Company Details
11.10.2 SHIFTBIO Business Overview
11.10.3 SHIFTBIO Exosome Therapeutics Introduction
11.10.4 SHIFTBIO Revenue in Exosome Therapeutics Business (2020-2025)
11.10.5 SHIFTBIO Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Exosome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Exosome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Exosome Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Exosome Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Exosome Therapeutics Market Share by Region (2020-2025)
Table 8. Global Exosome Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Exosome Therapeutics Market Share by Region (2026-2031)
Table 10. Exosome Therapeutics Market Trends
Table 11. Exosome Therapeutics Market Drivers
Table 12. Exosome Therapeutics Market Challenges
Table 13. Exosome Therapeutics Market Restraints
Table 14. Global Exosome Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Exosome Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Exosome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2024)
Table 17. Ranking of Global Top Exosome Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Exosome Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Exosome Therapeutics, Product and Application
Table 21. Global Key Players of Exosome Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Exosome Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Exosome Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Exosome Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Exosome Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Exosome Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Exosome Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Exosome Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Exosome Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Exosome Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Exosome Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cellular Biomedicine Group Company Details
Table 47. Cellular Biomedicine Group Business Overview
Table 48. Cellular Biomedicine Group Exosome Therapeutics Product
Table 49. Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Cellular Biomedicine Group Recent Development
Table 51. Codiak BioSciences Company Details
Table 52. Codiak BioSciences Business Overview
Table 53. Codiak BioSciences Exosome Therapeutics Product
Table 54. Codiak BioSciences Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Codiak BioSciences Recent Development
Table 56. Coya Therapeutics Company Details
Table 57. Coya Therapeutics Business Overview
Table 58. Coya Therapeutics Exosome Therapeutics Product
Table 59. Coya Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Coya Therapeutics Recent Development
Table 61. Curexsys Company Details
Table 62. Curexsys Business Overview
Table 63. Curexsys Exosome Therapeutics Product
Table 64. Curexsys Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Curexsys Recent Development
Table 66. EV Therapeutics Company Details
Table 67. EV Therapeutics Business Overview
Table 68. EV Therapeutics Exosome Therapeutics Product
Table 69. EV Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 70. EV Therapeutics Recent Development
Table 71. Evox Therapeutics Company Details
Table 72. Evox Therapeutics Business Overview
Table 73. Evox Therapeutics Exosome Therapeutics Product
Table 74. Evox Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Evox Therapeutics Recent Development
Table 76. ExoCoBio Company Details
Table 77. ExoCoBio Business Overview
Table 78. ExoCoBio Exosome Therapeutics Product
Table 79. ExoCoBio Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 80. ExoCoBio Recent Development
Table 81. ILIAS Biologics Company Details
Table 82. ILIAS Biologics Business Overview
Table 83. ILIAS Biologics Exosome Therapeutics Product
Table 84. ILIAS Biologics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 85. ILIAS Biologics Recent Development
Table 86. Rion Company Details
Table 87. Rion Business Overview
Table 88. Rion Exosome Therapeutics Product
Table 89. Rion Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Rion Recent Development
Table 91. SHIFTBIO Company Details
Table 92. SHIFTBIO Business Overview
Table 93. SHIFTBIO Exosome Therapeutics Product
Table 94. SHIFTBIO Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 95. SHIFTBIO Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Exosome Therapeutics Picture
Figure 2. Global Exosome Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Exosome Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monotherapy Features
Figure 5. Combination Therapy Features
Figure 6. Global Exosome Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Exosome Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Exosome Therapeutics Report Years Considered
Figure 13. Global Exosome Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Exosome Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Exosome Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Exosome Therapeutics Market Share by Players in 2024
Figure 17. Global Top Exosome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Exosome Therapeutics Revenue in 2024
Figure 19. North America Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Exosome Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Exosome Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Exosome Therapeutics Market Share by Region (2020-2031)
Figure 33. China Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Exosome Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Exosome Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Cellular Biomedicine Group Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 49. Codiak BioSciences Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 50. Coya Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 51. Curexsys Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 52. EV Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 53. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 54. ExoCoBio Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 55. ILIAS Biologics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 56. Rion Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 57. SHIFTBIO Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Exosome Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monotherapy
Table 3. Key Players of Combination Therapy
Table 4. Global Exosome Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Exosome Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Exosome Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Exosome Therapeutics Market Share by Region (2020-2025)
Table 8. Global Exosome Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Exosome Therapeutics Market Share by Region (2026-2031)
Table 10. Exosome Therapeutics Market Trends
Table 11. Exosome Therapeutics Market Drivers
Table 12. Exosome Therapeutics Market Challenges
Table 13. Exosome Therapeutics Market Restraints
Table 14. Global Exosome Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Exosome Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Exosome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2024)
Table 17. Ranking of Global Top Exosome Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Exosome Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Exosome Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Exosome Therapeutics, Product and Application
Table 21. Global Key Players of Exosome Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Exosome Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Exosome Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Exosome Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Exosome Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Exosome Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Exosome Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Exosome Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Exosome Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Exosome Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Exosome Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Exosome Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Exosome Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Exosome Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Cellular Biomedicine Group Company Details
Table 47. Cellular Biomedicine Group Business Overview
Table 48. Cellular Biomedicine Group Exosome Therapeutics Product
Table 49. Cellular Biomedicine Group Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Cellular Biomedicine Group Recent Development
Table 51. Codiak BioSciences Company Details
Table 52. Codiak BioSciences Business Overview
Table 53. Codiak BioSciences Exosome Therapeutics Product
Table 54. Codiak BioSciences Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Codiak BioSciences Recent Development
Table 56. Coya Therapeutics Company Details
Table 57. Coya Therapeutics Business Overview
Table 58. Coya Therapeutics Exosome Therapeutics Product
Table 59. Coya Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Coya Therapeutics Recent Development
Table 61. Curexsys Company Details
Table 62. Curexsys Business Overview
Table 63. Curexsys Exosome Therapeutics Product
Table 64. Curexsys Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Curexsys Recent Development
Table 66. EV Therapeutics Company Details
Table 67. EV Therapeutics Business Overview
Table 68. EV Therapeutics Exosome Therapeutics Product
Table 69. EV Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 70. EV Therapeutics Recent Development
Table 71. Evox Therapeutics Company Details
Table 72. Evox Therapeutics Business Overview
Table 73. Evox Therapeutics Exosome Therapeutics Product
Table 74. Evox Therapeutics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Evox Therapeutics Recent Development
Table 76. ExoCoBio Company Details
Table 77. ExoCoBio Business Overview
Table 78. ExoCoBio Exosome Therapeutics Product
Table 79. ExoCoBio Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 80. ExoCoBio Recent Development
Table 81. ILIAS Biologics Company Details
Table 82. ILIAS Biologics Business Overview
Table 83. ILIAS Biologics Exosome Therapeutics Product
Table 84. ILIAS Biologics Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 85. ILIAS Biologics Recent Development
Table 86. Rion Company Details
Table 87. Rion Business Overview
Table 88. Rion Exosome Therapeutics Product
Table 89. Rion Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Rion Recent Development
Table 91. SHIFTBIO Company Details
Table 92. SHIFTBIO Business Overview
Table 93. SHIFTBIO Exosome Therapeutics Product
Table 94. SHIFTBIO Revenue in Exosome Therapeutics Business (2020-2025) & (US$ Million)
Table 95. SHIFTBIO Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Exosome Therapeutics Picture
Figure 2. Global Exosome Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Exosome Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Monotherapy Features
Figure 5. Combination Therapy Features
Figure 6. Global Exosome Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Exosome Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics & Ambulatory Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Others Case Studies
Figure 12. Exosome Therapeutics Report Years Considered
Figure 13. Global Exosome Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Exosome Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Exosome Therapeutics Market Share by Region: 2024 VS 2031
Figure 16. Global Exosome Therapeutics Market Share by Players in 2024
Figure 17. Global Top Exosome Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Exosome Therapeutics Revenue in 2024
Figure 19. North America Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Exosome Therapeutics Market Share by Country (2020-2031)
Figure 21. United States Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Exosome Therapeutics Market Share by Country (2020-2031)
Figure 25. Germany Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Exosome Therapeutics Market Share by Region (2020-2031)
Figure 33. China Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Exosome Therapeutics Market Share by Country (2020-2031)
Figure 41. Mexico Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Exosome Therapeutics Market Share by Country (2020-2031)
Figure 45. Turkey Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Exosome Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Cellular Biomedicine Group Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 49. Codiak BioSciences Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 50. Coya Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 51. Curexsys Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 52. EV Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 53. Evox Therapeutics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 54. ExoCoBio Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 55. ILIAS Biologics Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 56. Rion Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 57. SHIFTBIO Revenue Growth Rate in Exosome Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232